Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
agree on the electronics only, and it's only a matter of time before this "code" is found and duplicated, not sure S/N is any safer bet than S/N on dollar bills, data bases fail and are also hacked. I remember a lot of microchips from TI, etc., used S/Ns, yet a data base doesn't exist, same with if ALL went to S/Ns now, even the plain NAND, AND, and NOR gates, the data base isn't there to prove the S/N is/isn't a used component. Anyway, there goes a lot more money thrown at the study, so presumably it will be used.
Northrop Grumman zeroes-in on technologies to protect military from counterfeit electronics
July 11, 2016
ByJohn Keller
Editor
counterfeit electronics ARLINGTON, Va., 11 July 2016. Defense microelectronics experts at the Northrop Grumman Corp. Mission Systems segment in Linthicum, Md., are moving forward on a U.S. military research initiative to safeguard the military electronics supply chain from substandard used and counterfeit electronics.
Officials of the U.S. Defense Advanced Research projects Agency (DARPA) in Arlington, Va., announced a $7.3 million contract option on Friday for the second phase of the DARPA Supply Chain Hardware Integrity for Electronics Defense (SHIELD) program.
In the program's second phase Northrop Grumman engineers will continue work on a tool to verify the trustworthiness of protected electronic components without disrupting or harming the system into which they have been designed.
Used and counterfeit electronic components are widespread throughout the defense supply chain, DARPA officials say. Suspect electronic components present a critical risk in military systems where a malfunction of a single part could lead to system failures that can put warfighter lives and missions at risk.
In the SHIELD program's first phase Northrop Grumman experts worked to develop a 100-by-100-micron component, or dielet, that authenticates electronics components. The dielets have encryption engines and sensors to detect tampering that affix to electronic components like microchips.
Related: What if we considered selling counterfeit electronic parts like we do selling stolen property?
The SHIELD program's goal is to provide 100 percent assurance against recycled components that are sold as new; unlicensed overproduction of authorized components; test rejects and sub-standard components sold as high-quality; parts marked with falsely elevated reliability or newer date of manufacture; low-quality clones and copies that may include hidden functionality; and components that are covertly repackaged for unauthorized applications, DARPA officials say.
SRI International in Menlo Park, Calif., and the Charles Stark Draper Laboratory in Cambridge, Mass., joined Northrop Grumman on the DARPA SHIELD program's first phase. The three companies won SHIELD phase-one contracts in January 2015.
"SHIELD demands a tool that costs less than a penny per unit, yet makes counterfeiting too expensive and technically difficult to do,” says Kerry Bernstein, the SHIELD program manager at DARPA.
"The dielet will be designed to be robust in operation, yet fragile in the face of tampering," Bernstein says. "What SHIELD is seeking is a very advanced piece of hardware that will offer an on-demand authentication method never before available to the supply chain."
Related: SRI, Northrop, and Draper to safeguard military from counterfeit electronics
Northrop Grumman, Draper, and SRI experts in phase one developed dielets that can be inserted into an electronic component’s package at the manufacturing site or affixed to existing trusted components, without any alteration of the host component’s design or reliability.
The companies designed dielets with no electrical connections to the host component, such that authenticity testing can be done anywhere with a handheld or automated probes. After a scan, an inexpensive appliance like a smart phone will upload a serial number to a central, industry-owned server. The server sends an unencrypted challenge to the dielet, which sends back an encrypted answer and data from passive sensors—like light exposure—that could indicate tampering.
The contract option announced Friday brings the total cumulative face value of the company's SHIELD contract to $19.6 from $12.3 million. On the second phase Northrop Grumman will do the work in Linthicum, Md.; Albuquerque, N.M.; Santa Clara, Calif.; Reston, Va.; Lubbock, Texas; and Atlanta, and should be finished by January 2018.
For more information contact Northrop Grumman Mission Systems online at www.northropgrumman.com, or DARPA at www.darpa.mil.
http://www.nasdaq.com/article/earnings-reported-after-the-bell-dec-14-20151215-00069?cid=stockalerts
not looking bad financially at all
LOL, absolutely agree with you on the ambulance chasers. It is also part of my feel that the climb will be slow, unless earth-shattering PR. Another legal group just the other day had announced their "investigation" keeping the jitters alive. Didn't have a thing to do with "shorters".
good attitude! I was just opin on that it wasn't as good a PR as having the SEC more than just informed. They get tips every day.
yes, I saw that. Doubt he's bright enough to run, wasn't bright enough not to pull the stunt he did.
Hope you're right about pre-financials, but as to other, I was quoting APDN. Anyone that did DD on the company would not have dumped the stock as hard as it went down.
"the false and misleading statements and innuendos stated". Only can get him for false. And those false statements may have not been a huge false worthy of prison time, just taking the short position and then making article on SA, well, have seen that before, SA got in trouble for it, but has the disclaimers in place now. Constantly see shorter articles there. The word play alone in today's PR doesn't give any of us a good enough stance to put in a SA article to try and "pump" it back up. Have to wait for the SEC.
yes, knew the road would lead here. But note APDN used FORMER law enforcement to track down the shorters. Doesn't give me (and other investors out there) a huge fuzzy feeling to get the stock back to where it was, and certainly no mention of the feds in the released statement. Nor will we ever see restitution of any kind. So now we're still stuck waiting for next quarter's finances, and do the slow dance back up.
Only one east coast and one west coast firm jumped into the class action suit arena, before checking out the claims. Usually, see 5 or 6 if there was any real merit of SEC violation. Anyone verify this $33M compensation? Or was he just talking and including payroll here? Company had always ran in the red, what has helped bring it up, is reducing the negative cash flow.
lost me Pasta, is the Shorter suing APDN?
Not a very good response from Hayward, but it was quick enough. All have to realize, their execs have a ton of the stock and just went to half value.
If all was questionable, SEC would be on it already from a whistleblower
The result is what the author intended, panic selling. Seeking Alpha has been (unsuccessfully) sued in the past for allowing articles intended for stock manipulation. Supposedly, the authors must disclose their position.
It is too soon for APDN to have responded, they have to go thru their legal attorneys. Article talks about promos years ago, which is misleading, but not libelous material, same with the DOD contracts that expire next year.
I do notice they quoted our old buddies at Rochester, LOL. That really weighs a lot (NOT).
Well, my take is that it was just a "why buy this stock when it isn't running in the black....". Afraid the video kept breaking up on me to point it seemed questions were being asked before answer was fully given. If he only stuck to cloaking as you indicated, then not sure why all the tentacles of APDN were being held back, could be something held back deliberately??? Site seems to be linked to Jim Cramer, who rose to stardome because he picked a good stock once upon a time, LOL. Most of his followers short stocks that he recommends, just because they expect a spike due to the exposure. Not a fan of Cramer at all myself.
being my honest self, it makes me nervous with the daily PRs. Small and particularly microcaps usually have a pact with the devil over giving away blocks of stock at a discount. Usually, to pay for something, such as a $1.5 million purchase ;) and go into mass PRs, most with little substance.
Then, there's investors looking for under $5 deals and something not tied to Fed rate, precious metals, China, or oil right now. APDN is growing, for years we've been watching it temporary surge on the belief that it is go into the black. The things the media isn't telling you is how much individual Chinese investors have been pulling their money out of the U.S. market as the yuan is devalued.
Note the date on the below:
Healthcare ratings roundup - new coverage
May 26 2015, 13:43 ET | By: Douglas W. House, SA News Editor [Contact this editor with comments or a news tip]
Blueprint Medicines (BPMC -1.8%) initiated with Outperform rating and $41 (37% upside) price target by Wedbush.
Applied DNA Sciences (APDN -1.6%) initiated with Speculative Buy rating and $5 (100% upside) price target by Benchmark.
http://seekingalpha.com/news/2544006-healthcare-ratings-roundup-new-coverage
not what all the fuss has been about.
It means they make federal standards for externally auditing/sampling their products for specifications requirements, such as particle/million, temperature range, etc. Even their quality plan gets reviewed.
Very nice statement. I can see how that might expand APDN's whole product area, expanding into far more than tagging.
thanks, still here and living the limit of free membership only. Anyway, "Vandalia is using these tools to market DNA products and services to industrial, education, and government institutions. In addition, Vandalia is seeking strategic partnerships to broaden the use of our novel instrumentation and manufacturing techniques." Maybe they'll open a few doors, maybe not. Must of been sticker shock for them starting as a University research with funding, then trying to go commercial and make a buck.... But must have/add some value to get bought out.
http://www.nasdaq.com/press-release/applied-dna-sciences-acquires-assets-of-dna-manufacturer-vandalia-research-20150911-00661
Strengthens Large Scale DNA Production and Broadens Market Reach
STONY BROOK, NY -- (Marketwired) -- 09/11/15 -- Applied DNA Sciences, Inc.(NASDAQ:APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology, product genotyping services and product authentication solutions, announced that it has acquired the assets of privately held Vandalia Research, Inc. for $1.5 million in cash.
Vandalia's core technology and intellectual property portfolio, allow for the large-scale production of specific DNA sequences using polymerase chain reaction (PCR). PCR can amplify a few copies of a piece of DNA, generating millions to billions of copies without the impurities of fermentation.
Vandalia's Triathlon™ PCR systems are self-contained and modular, can work together in mass production or can be used individually throughout the world, offering the advantage of delivering DNA locally and securely. The enclosed design should facilitate compliance with drug manufacturing guidelines in our quest to DNA mark individual doses as a major initiative in the war against counterfeit drugs. "Expanding our manufacturing capacity through the acquisition of Vandalia's Triathlon PCR machines is opportune as we move toward converting pilot projects to commercial deployment, and creates, we believe, the world's largest manufacturing capacity of DNA in bulk using PCR," said Dr. James Hayward, President and CEO of APDN. "Self-contained production, paired with our On-Site™ DNA Authentication Program that can be done with simple training, opens the opportunity for rapid deployment of DNA marking in response to the anti-counterfeiting needs of the military, border protection, law enforcement agencies and supply chains."
The acquisition provides APDN with established supply relationships across key companies in the biotechnology, pharmaceutical and diagnostic markets where Vandalia DNA is already used as a business-critical therapeutic, diagnostic and reagent and provides the company the opportunity to cross-sell its DNA-based supply chain security solutions. There will be no lapse in DNA production as we fulfil Vandalia's current backlog and expected orders through the remainder of the current quarter and beyond.
A new capacity for APDN will be the ability to manufacture longer DNA sequences valuable in gene therapy, DNA vaccines and diagnostics. These types of DNA are distinct from APDN's security markers and represent a new entry into medical markets, where management believes there are ample opportunities for APDN's broader platform.
Derek Gregg, former CEO of Vandalia and co-inventor of its Triathlon platform, will join APDN as a consultant focused on the sale of DNA to the biotechnology and drug development industry. The company intends to move the physical assets of Vandalia to its headquarters in Long Island before the end of 2015.
Dr. Hayward continued, "We are in the midst of a coordinated effort to use SigNature DNA to bring supply chain security to pharmaceutics and foods and, as part of this, it is essential that we immediately begin the process of becoming compliant with cGMP (Current Good Manufacturing Practice) guidelines so that we may improve these supply chains just as we have in cotton. We believe that Vandalia's Triathlon can help us to expedite this process. We look forward to working with our new colleagues from Vandalia, creating demand for DNA and setting new records for its production."
About Applied DNA Sciences
We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA describes the platform ingredient that is at the heart of all of our security and authentication solutions. SigNature DNA is at the core of a family of uncopyable products such as DNAnet®, our anti-theft product, SigNature® T and fiberTyping®, targeted toward textiles, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence and can be used to prosecute perpetrators.
Applied DNA Sciences common stock is listed on NASDAQ under the symbol APDN, and its warrants are listed under the symbol APDNW.
Forward Looking Statements
The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 15, 2014, as amended on March 6, 2015, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2015, May 11,2015 and August 10, 2015, which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.
Investor contact:
Debbie Bailey
631-240-8817
Email contact
Media contact:
Susan Forman
Dian Griesel Int'l.
212-825-3210
Email contact
Web:Email contact
twitter: @APDN
Source: Applied DNA Sciences
This article appears in: News Headlines
Referenced Stocks: APDN
Healthcare ratings roundup - new coverage
May 26 2015, 13:43 ET | By: Douglas W. House, SA News Editor
Blueprint Medicines (BPMC -1.8%) initiated with Outperform rating and $41 (37% upside) price target by Wedbush.
Applied DNA Sciences (APDN -1.6%) initiated with Speculative Buy rating and $5 (100% upside) price target by Benchmark.
StemCells (STEM +1.2%) initiated with Buy rating with $2 (190% upside) price target by Cantor Fitzgerald.
Horizon Pharma (HZNP -0.4%) initiated with Outperform rating and $37 (16% upside) price target by Leerink Swann.
Uniqure (QURE +1.7%) initiated with Outperform rating and $47 (74% upside) price target by Oppenheimer.
Sharps Compliance (SMED -2.3%) initiated with Buy rating and $8 (43% upside) price target by Stifel Nicolaus.
Barclays initiates coverage on four stocks: Overweight ratings on three: Alkermes plc (ALKS -2.9%) with $74 (23% upside) price target; Esperion Therapeutics (ESPR -3%) with $150 (43% upside) price target and Intercept Pharmaceuticals (ICPT +0.6%) with a $425 (62% upside) price target and an Equal Weight rating on Trevena (TRVN) with an $11 (62% upside) price target.
nice to be conservative, reduces disappointment in short term goals. 2017 is a very good guess to have almost all of the 66 categories (classes) added.
I fully expect this will expand into prime contractors having to go this route.... that was the only "big if" I had with the DLA one-stop marking, prime contractors (or any fed govt contractor for that matter, cannot purchase their parts/components from DLA. With the 60/40 rules, and all the new tech, added with NASA being privatized..... we are still stuck with counterfeit parts being put into govt equipment, ranging from substandard bolts and screws to microchips, arrays, complete power supplies, etc..
thanks WT1. LOVE, LOVE, LOVE this part:
"In August 2014, APDN won a competitive Rapid Innovation Fund (RIF) award. The goal of this RIF is to demonstrate the capability to mark and authenticate a diverse range of products, well beyond microcircuits. APDN will be working with manufacturers and suppliers of items in up to 66 additional federal supply classes who will be participating in this RIF and other federally funded programs."
66 CLASSES is HUGE, thousands upon thousands of individual stock numbers
I believe it is manual. It is a makeup from several plants, if I remember correctly, so that the DNA makeup isn't easily identifiable, then the addition of other DNA markers is added to make each one (for each customer) unique in itself.
If I understand your question correctly, the answer is yes. It is plant DNA with specific markers for each mfr., who then stores the "bottle" in their safe, and adds it to the carrier as per number of drops, etc. It could be added to the fabric itself at some point along the mfr process, whether still in fiber, such as cotton, or after it is woven. When it is to be added is first discussed and decided upon, so the formulation (amount per ink/material/etc.) is properly tested and determined for heat, humidity, aging, etc. that the intended product will be subjected to. You do throw me a bit with the "automated process" language.
thanks WTI, beat me to posting the links
GREAT FINANCIALS RELEASE
thanks WT1 and Shail. Definitely need some catching up. APDN overall has done ok considering the huge market selloff, and settled in about double it's pre-DOD mandate level, so even sad at it's decline, still positive about it holding it's own.
The increasing concern of terrorists infiltrating the supply chain is good for APDN, period. Summit is good, while the usual crowd of distributors claim they aren't the source, just customers swapping return parts. Uh-huh, and who's controlling the customer base they're selling to, verifying not a customer front? Can't sit there and claim the Military or high tech military companies like Lochheed or Raytheon for such bumbleing and mishandling of parts.
Yes, it's quite expensive to uplist, let alone the requirements of minimum profitability, etc. And that is just to register. Very much doubt this S-1 is a "rouse" to bring in investors, they've talked about uplisting 3 years now, and NOW have completed an S-1, unlike the previous years.
http://counterfeitparts.wordpress.com/2014/10/22/third-ndia-supply-chain-summit-tuesday-december-9th-crown-plaza-rockville-md/
I'll try to stick around a bit more, no promises. Been too busy to even have read APDN's latest financials, which I assumed from it's movement that day that it was more of the same ol' tune. Did manage to read the decision to not have EVERYBODY pay for the marking, that it was "single-sourced", But in the real focus of it, their markup wasn't that profitable, and too much of companies not properly protecting it anyway. So short-term, we take the hit, long-term, at least the usual group of "Not Me" distributors did not walk away with their demands of dropping the markers altogether and just buy from them.
Latest Military & Aerospace Electronics has good articles as usual, Unmanned Vehicles, although U.S. is slow in getting them, at least is modernizing the electronics guidance and control. Lochheed-Martin, Northrop-Grumman, and Curtiss-Wright top the list of new military contracts. Though APDN's markering system for DOD got kicked partially in the teeth, only time will tell if anti-counterfeiting efforts slides again.
FOX is claiming a great market recovery again tomorrow, LOL.
I'll try to keep in touch better. Sounds like you're doing OK yourself?????